Can sodium-glucose cotransporter-2 inhibitors stabilize coronary atherosclerotic plaques? Evidence from imaging studies.
作者信息
Gurgoglione Filippo Luca, Crea Filippo, Niccoli Giampaolo, Galli Mattia
机构信息
Division of Cardiology, University of Parma, Parma University Hospital, 43100 Parma, Italy.
Center of Excellence of Cardiovascular Sciences, Ospedale Isola Tiberina-Gemelli Isola, 00100 Rome, Italy.
出版信息
Eur Heart J Cardiovasc Pharmacother. 2025 Jul 7;11(4):323. doi: 10.1093/ehjcvp/pvaf025.
Abstract
摘要
相似文献
1
Can sodium-glucose cotransporter-2 inhibitors stabilize coronary atherosclerotic plaques? Evidence from imaging studies.钠-葡萄糖协同转运蛋白2抑制剂能否稳定冠状动脉粥样硬化斑块？来自影像学研究的证据。
Eur Heart J Cardiovasc Pharmacother. 2025 Jul 7;11(4):323. doi: 10.1093/ehjcvp/pvaf025.
2
Sodium-Glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome With Diabetes Mellitus.钠-葡萄糖共转运蛋白 2 抑制剂稳定糖尿病合并急性冠状动脉综合征患者的冠状动脉斑块。
Am J Cardiol. 2024 Mar 1;214:47-54. doi: 10.1016/j.amjcard.2023.12.056. Epub 2024 Jan 10.
3
Longitudinal assessment of coronary plaque regression related to sodium-glucose cotransporter-2 inhibitor using coronary computed tomography angiography.利用冠状动脉计算机断层扫描血管造影评估钠-葡萄糖共转运蛋白 2 抑制剂相关的冠状动脉斑块消退情况：一项纵向研究。
Cardiovasc Diabetol. 2024 Jul 22;23(1):267. doi: 10.1186/s12933-024-02368-y.
4
Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature.探究钠-葡萄糖协同转运蛋白2抑制剂以及钠-葡萄糖协同转运蛋白1/钠-葡萄糖协同转运蛋白2双重抑制剂在心力衰竭治疗中的地位：文献系统综述
Heart Fail Rev. 2024 Mar;29(2):549-558. doi: 10.1007/s10741-024-10388-9. Epub 2024 Feb 1.
5
Sodium-Glucose Cotransporter 2 Inhibitors: Possible Anti-Atherosclerotic Effects Beyond Glucose Lowering.钠-葡萄糖协同转运蛋白2抑制剂：除降糖作用外的潜在抗动脉粥样硬化效应
J Clin Med Res. 2016 Jan;8(1):10-4. doi: 10.14740/jocmr2385w. Epub 2015 Dec 3.
6
Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Acute Coronary Syndrome: A Modern Cinderella?钠-葡萄糖共转运蛋白 2 抑制剂在急性冠状动脉综合征患者中的应用：现代版灰姑娘？
Clin Ther. 2024 Nov;46(11):841-850. doi: 10.1016/j.clinthera.2024.06.010. Epub 2024 Jul 10.
7
Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium-glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitors.接受经皮冠状动脉介入治疗的 2 型糖尿病患者应用钠-葡萄糖共转运蛋白 2 抑制剂与二肽基肽酶-4 抑制剂治疗的心血管、肾脏和下肢结局。
Eur Heart J Cardiovasc Pharmacother. 2023 Jun 2;9(4):301-310. doi: 10.1093/ehjcvp/pvad004.
8
Obesity Treatments to Improve Type 1 Diabetes (OTID): a randomized controlled trial of the combination of glucagon-like peptide 1 analogues and sodium-glucose cotransporter 2 inhibitors-protocol for Obesity Treatments to Improve Type 1 Diabetes (the OTID trial).改善 1 型糖尿病的肥胖治疗（OTID）：胰高血糖素样肽 1 类似物和钠-葡萄糖共转运蛋白 2 抑制剂联合治疗的随机对照试验——改善 1 型糖尿病的肥胖治疗（OTID 试验）方案。
Trials. 2024 Feb 16;25(1):129. doi: 10.1186/s13063-024-07930-3.
9
Sodium-glucose cotransporter-1 inhibition and depression: A Mendelian randomization study.钠-葡萄糖协同转运蛋白1抑制与抑郁症：一项孟德尔随机化研究。
SAGE Open Med. 2025 Jul 2;13:20503121251352618. doi: 10.1177/20503121251352618. eCollection 2025.
10
Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events.钠-葡萄糖共转运蛋白 2 抑制剂：对动脉粥样硬化和动脉粥样硬化性心血管疾病事件的影响。
Heart Fail Clin. 2022 Oct;18(4):597-607. doi: 10.1016/j.hfc.2022.03.007.
引用本文的文献
1
Advances in the Detection and Management of Vulnerable Coronary Plaques.易损冠状动脉斑块的检测与管理进展
Circ Cardiovasc Interv. 2025 Aug;18(8):e015529. doi: 10.1161/CIRCINTERVENTIONS.125.015529. Epub 2025 Jul 28.
本文引用的文献
1
2024 ESC Guidelines for the management of chronic coronary syndromes.2024年欧洲心脏病学会慢性冠状动脉综合征管理指南
Eur Heart J. 2024 Sep 29;45(36):3415-3537. doi: 10.1093/eurheartj/ehae177.
2
Longitudinal assessment of coronary plaque regression related to sodium-glucose cotransporter-2 inhibitor using coronary computed tomography angiography.利用冠状动脉计算机断层扫描血管造影评估钠-葡萄糖共转运蛋白 2 抑制剂相关的冠状动脉斑块消退情况：一项纵向研究。
Cardiovasc Diabetol. 2024 Jul 22;23(1):267. doi: 10.1186/s12933-024-02368-y.
3
Sodium-Glucose Cotransporter-2 Inhibitors Stabilize Coronary Plaques in Acute Coronary Syndrome With Diabetes Mellitus.钠-葡萄糖共转运蛋白 2 抑制剂稳定糖尿病合并急性冠状动脉综合征患者的冠状动脉斑块。
Am J Cardiol. 2024 Mar 1;214:47-54. doi: 10.1016/j.amjcard.2023.12.056. Epub 2024 Jan 10.
4
SGLT2-inhibitors effects on the coronary fibrous cap thickness and MACEs in diabetic patients with inducible myocardial ischemia and multi vessels non-obstructive coronary artery stenosis.钠-葡萄糖协同转运蛋白 2 抑制剂对伴有可诱导性心肌缺血和多支非阻塞性冠状动脉狭窄的糖尿病患者冠状动脉纤维帽厚度和主要不良心血管事件的影响。
Cardiovasc Diabetol. 2023 Apr 1;22(1):80. doi: 10.1186/s12933-023-01814-7.
Zotero 插件